In the latest edition of the Penningtons Manches Cooper LLP BioBrief newsletter, their team explores university-generated IP and in particular what it means for students who are involved and contributing to such IP...
Read more.
Lab-on-chip technology for screening live tumor
Glasgow, UK based – ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies on live tissue samples.
Combining the latest advances in microfluidics and 3D cell culture – ScreenIn3D’s unique chip technology enables researchers to use as few as 1000 cells for tens of 3D cancer screening experiments. ScreenIn3D has recently secured investment…
Cambridge, UK, 30th August 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr. Tomasz Kostrzewski as Chief Scientific Officer. Previously Vice President of Science and Technology, Dr. Kostrzewski’s promotion creates a new position in CN Bio’s leadership team, marking another key milestone in the Company’s development as the fourth leadership-level appointment within the past year.
Dr. Kostrzewski has more than 15 years of experience in molecular and cellular biology…
Cambridge, UK / Waltham, MA, August 28, 2023 – Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced today that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (‘Danaher’) will acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the ‘Transaction’).
The Transaction has been unanimously approved and recommended by the Abcam Board of Directors and unanimously approved by the Danaher Board of Directors.
Founded in 1998 and…
Oxford, UK - British techbio innovator Etcembly is coming out of stealth mode, kickstarting the next generation of immunotherapies with a pipeline of best-in-class T cell receptor (TCR) therapeutics designed using generative AI.
The company’s lead therapeutic programme, ETC-101, is the world’s first AI-designed bispecific T cell engager. It targets PRAME, a validated antigen present in many cancers but absent from healthy tissue.
The lead asset currently demonstrates single digit picomolar affinity – a million-fold higher affinity than the native receptor – with no known cross-reactivity…
Babraham Research Campus and Global proptech leader Equiem have announced a partnership that will provide an enhanced experience for the Campus’s life science community in Cambridge. The collaboration will create one central communication hub that will add value to the service offering for Babraham Research Campus companies and enhance the overall experience of life on Campus.
Occupiers will have access to the Equiem One platform where they can contribute their own content, and share news and company updates to promote their activities across the Campus community. The Equiem One platform…
As part of The Business Journals’ Bizwomen feature, BioMed Realty’s Colleen O'Connor authored an article to share insights and advice from her successful career in life sciences real estate. In her current role – Senior Vice President, Leasing, East Coast and UK Markets – Colleen helps to foster the growth of vibrant innovation communities in the Greater Boston area and in the UK. She also makes it a priority to mentor young professionals as they enter the industry.Colleen wrote: “In 2019, I joined CREW Boston to help other women in real estate navigate the industry…
London, 17 August 2023 – Global life sciences strategy, design, and construction firm, Unispace Life Sciences, has acquired UK laboratory and office fit-out specialist Bulb. This is the second life sciences design company the business welcomes in less than two years, after attaining BioPharma Engineering (BPE) in Cork, Ireland in 2022. Bulb will operate as ‘Unispace Life Sciences’, part of the Unispace Group, with a highly experienced team fully dedicated to creating inspiring facilities, labs and workplaces for this sector.
This is another significant step for the business’ life…
Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR TO COLLABORATE WITH TOP 10 GLOBAL PHARMACEUTICAL COMPANY
Arecor expands its global partnerships through collaboration to develop an enhanced antibody formulation
Cambridge, UK, 17 August 2023: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed an agreement with a top 10 pharmaceutical company to develop an enhanced antibody formulation for one of its investigational drugs.
Under the terms of this agreement, Arecor will use its…
Hello to all ON members,
We are thrilled to announce that MedFlow Clinical has officially joined the prestigious ranks of One Nucleus.
As a new member of this esteemed network, we eagerly anticipate the remarkable opportunities that lie ahead.
Our team is excited to engage with the vibrant community of Life Science professionals within One Nucleus, and we are eagerly looking forward to forging meaningful connections, sharing insights, and collaborating on cutting-edge advancements in the field.
Through this partnership, we are confident that MedFlow Clinical will contribute to, and benefit…